Shopping Cart
- Remove All
- Your shopping cart is currently empty
Palbociclib hydrochloride (pabociclib hydrochloride) is the salt form of Palbociclib, a selective and orally available CDK4 and CDK6 inhibitor with anti-tumor proliferative activity for use in breast and hepatocellular carcinoma.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $31 | In Stock | |
5 mg | $47 | In Stock | |
10 mg | $73 | In Stock | |
1 mL x 10 mM (in DMSO) | $58 | In Stock |
Description | Palbociclib hydrochloride (pabociclib hydrochloride) is the salt form of Palbociclib, a selective and orally available CDK4 and CDK6 inhibitor with anti-tumor proliferative activity for use in breast and hepatocellular carcinoma. |
Targets&IC50 | CDK4-CyclinD3:9 nM, CDK6-CyclinD2:16 nM, MAPK:8000 nM, Dyrk1A:2000 nM, CDK4-CyclinD1:11 nM |
In vitro | Methods: Huh7 and skHep1 cells were treated with Palbociclib hydrochloride (0.1, 0.5 μM, 10 days) to test the reversibility of cell cycle arrest. Results: Palbociclib hydrochloride may induce irreversible cell cycle arrest in both cell lines, which may be dose-dependent. [2] |
In vivo | Methods: Palbociclib hydrochloride (40 mg/kg, oral, 17 days) was used to treat NSG mice bearing IMR32 neuroblastoma cells to study its effect on tumor growth in mice. Results: Palbociclib hydrochloride effectively inhibited tumor growth in NSG mice and had no obvious toxicity to mice. [1] |
Alias | TQB-3616 hydrochloride, TQB3616 hydrochloride, PD-0332991 hydrochloride, PD0332991 hydrochloride |
Molecular Weight | 520.46 |
Formula | C24H31Cl2N7O2 |
Cas No. | 571189-11-2 |
Storage | keep away from moisture | store at 4°C | Shipping with blue ice. | ||||||||||
Solubility Information | H2O: 1.00 mg/mL (1.92 mM), Sonication is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
H2O
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.